MIF-1 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
MIF-1 is being researched for anxiety applications. Acts as a positive allosteric modulator of D2 and D4 dopamine receptors while simultaneously blocking opioid receptor activation. Inhibits release of alpha-MSH and potentiates melatonin activity, crea. Common dosages for this use range from 1-10 mg once daily.
Can MIF-1 Help With Anxiety?
MIF-1 (Pro-Leu-Gly-NH2 (Melanocyte-inhibiting factor-1)) is being researched for anxiety applications based on its mechanism as a Neuropeptide, dopamine receptor modulator.
Acts as a positive allosteric modulator of D2 and D4 dopamine receptors while simultaneously blocking opioid receptor activation. Inhibits release of alpha-MSH and potentiates melatonin activity, creating a complex neurochemical profile affecting mood, motor function, and reward signaling.
What Does the Research Show for MIF-1 and Anxiety?
Extensively studied in animal models showing antidepressant and nootropic effects through multiple neurotransmitter systems. Multiple peer-reviewed studies from 1980s-1990s. No human clinical trials.
The relevance to anxiety specifically comes from MIF-1's effects on antidepressant effects, nootropic enhancement, anti-Parkinsonian action, dopamine modulation.
What Protocol Is Used for Anxiety?
For anxiety applications, the standard MIF-1 protocol is 1-10 mg administered once daily via subcutaneous injection (poorly active orally) for not established; short protocols in research.
Some researchers adjust dosing based on the specific anxiety application — see our MIF-1 dosage guide for full protocol details.
Can Stacking Improve Anxiety Results?
Pairs with dopamine-enhancing compounds (L-DOPA) to amplify dopaminergic effects through allosteric modulation.
What Side Effects Apply to Anxiety Use?
Limited human data. Inverted U-curve response — loses efficacy at very high doses. No serious adverse effects documented.
Side effects are generally consistent regardless of the specific application. See our MIF-1 side effects guide for details.
Calculate Your MIF-1 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MIF-1.
Open Calculator →Bottom Line: MIF-1 for Anxiety
MIF-1 shows preliminary research potential for anxiety. Standard protocols (1-10 mg, once daily, not established; short protocols in research) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
MIF-1 : Benefits, Dosage, Side Effects & Research
Related Reading
- MIF-1 Dosage Guide
- MIF-1 Benefits
- MIF-1 Side Effects
- MIF-1 Stacking Guide
- MIF-1 Cycle Guide
- MIF-1 Research
Research-Grade Sourcing
If you're going to research MIF-1, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MIF-1?
MIF-1 (Pro-Leu-Gly-NH2 (Melanocyte-inhibiting factor-1)) is a Neuropeptide, dopamine receptor modulator. Endogenous tripeptide derived from cleavage of oxytocin, produced primarily by the hypothalamus. It is researched for antidepressant effects, nootropic enhancement, anti-Parkinsonian action, dopamine modulation.
What is the recommended MIF-1 dosage?
Common dosages: 1-10 mg administered once daily via subcutaneous injection (poorly active orally). Cycle length: not established; short protocols in research. Half-life: resistant to bloodstream metabolism; crosses blood-brain barrier. Use our peptide calculator for exact reconstitution math.
What are the side effects of MIF-1?
Limited human data. Inverted U-curve response — loses efficacy at very high doses. No serious adverse effects documented.
Is MIF-1 safe?
MIF-1 has shown a preliminary safety profile in research. Not FDA-approved. Research chemical. All research should follow appropriate safety protocols.